Authors:
MCCULLOCH RK
WALKER CE
CHAKERA A
JAZAYERI J
LEEDMAN PJ
Citation: Rk. Mcculloch et al., REGULATION OF EGF-RECEPTOR EXPRESSION BY EGF AND TGF-ALPHA IN EPIDERMOID CANCER-CELLS IS CELL-TYPE-SPECIFIC, International journal of biochemistry & cell biology, 30(11), 1998, pp. 1265-1278
Authors:
MCCULLOCH RK
SELLNER LN
PAPADIMITROU JM
TURBETT GR
Citation: Rk. Mcculloch et al., THE INCIDENCE OF MICROSATELLITE INSTABILITY AND LOSS OF HETEROZYGOSITY IN FIBROADENOMA OF THE BREAST, Breast cancer research and treatment, 49(2), 1998, pp. 165-169
Citation: Cs. Choong et al., REDUCED EXPRESSION AND NORMAL NUCLEOTIDE-SEQUENCE OF ANDROGEN RECEPTOR GENE CODING AND PROMOTER REGIONS IN A FAMILY WITH PARTIAL ANDROGEN INSENSITIVITY SYNDROME, Clinical endocrinology, 46(3), 1997, pp. 281-288
Citation: Cs. Choong et al., PARTIAL ANDROGEN INSENSITIVITY CAUSED BY AN ANDROGEN RECEPTOR MUTATION AT AMINO-ACID-907 (GLY-]ARG) THAT RESULTS IN DECREASED LIGAND-BINDING AFFINITY AND REDUCED ANDROGEN RECEPTOR MESSENGER-RIBONUCLEIC-ACID LEVELS, The Journal of clinical endocrinology and metabolism, 81(1), 1996, pp. 236-243
Citation: Rk. Mcculloch et al., AN EVALUATION OF COMPETITOR TYPE AND SIZE FOR USE IN THE DETERMINATION OF MESSENGER-RNA BY COMPETITIVE PCR, PCR methods and applications, 4(4), 1995, pp. 219-226
Citation: Y. Chen et al., SYNTHESIS OF ALBUMIN-DEXTRAN SULFATE MICROSPHERES POSSESSING FAVORABLE LOADING AND RELEASE CHARACTERISTICS FOR THE ANTICANCER DRUG DOXORUBICIN, Journal of controlled release, 31(1), 1994, pp. 49-54